Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00036205
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
RIV | 5-chloro-N-({(5S)-2-oxo-3-[4-(3- oxomorpholin-4-yl)phenyl]-1,3-oxazolidin- 5-yl}methyl)thiophene-2-carboxamide | A | 2W26 | 0.7 | |
LZF | 5-chloro-N-[(3S,4S)-1-(2-{[2-fluoro- 4-(2-oxopyridin-1(2H)-yl)phenyl]amino}- 2-oxoethyl)-4-methoxypyrrolidin- 3-yl]thiophene-2-carboxamide | A,B | 2VVC | 0.7 | |
BDK | 2-[5-AMINO-6-OXO-2-(2-THIENYL)- 1,6-DIHYDROPYRIMIDIN-1-YL)-N-[3,3- DIFLUORO -1-ISOPROPYL-2-OXO-3-(N- (2-MORPHOLINO ETHYL)CARBAMOYL]PROPYL]ACETAMIDE | A | 1EAU | 0.72 | |
KCP | 2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)- METHYL]-5-METHYL-3,6-DIHYDRO-2H- [1,3]THIAZINE-4-CARBOXYLIC ACID | A,B | 1KVL | 0.78 | |
895 | 2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}ETHENESULFONAMIDE | D,H | 2JH5 | 0.73 | |
895 | 2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}ETHENESULFONAMIDE | A | 2UWL | 0.73 | |
CLS | CEPHALOTHIN | A,B | 1KVL | 0.75 | |
G23 | (2R,4S)-2-[(R)-BENZYLCARBAMOYL- PHENYLACETYL-METHYL]-5,5-DIMETHYL- THIAZOLIDINE-4-CARBOXYLIC ACID | A | 1HTE | 0.71 | |
THN | 2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)- METHYL]-5-METHYLENE-5,6-DIHYDRO- 2H-[1,3]THIAZINE-4-CARBOXYLIC ACID | A,B | 1KVL | 0.73 | |
160 | 3-(3-{2-[(5-METHANESULFONYL-THIOPHENE- 2-CARBONYL)-AMINO]-ETHYLDISULFANYLMETHYL}- BENZENESULFONYLAMINO)-4-OXO-PENTANOIC ACID | A,B | 1NMQ | 0.72 | |
CEP | CEPHALOTHIN GROUP | A | 1CEG | 0.77 | |
CEP | CEPHALOTHIN GROUP | A | 1IYP | 0.77 | |
NCF | (2R)-2-{(1R)-2-OXO-1-[(2-THIENYLACETYL)AMINO]ETHYL}- 5,6-DIHYDRO-2H-1,3-THIAZINE-4-CARBOXYLIC ACID | A,B,C,D | 1W8Y | 0.73 | |
UBA | (S)-1-(2-AMINO-2-CARBOXYETHYL)- 3(2-CARBOXYTHIOPHENE-3-YL-METHYL)- 5-METHYLPYRIMIDINE-2,4-DIONE | A,B | 2F34 | 0.73 | |
UBA | (S)-1-(2-AMINO-2-CARBOXYETHYL)- 3(2-CARBOXYTHIOPHENE-3-YL-METHYL)- 5-METHYLPYRIMIDINE-2,4-DIONE | A,B | 2OJT | 0.73 | |
894 | 2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}ETHANESULFONAMIDE | A | 2UWP | 0.72 | |
894 | 2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}ETHANESULFONAMIDE | D,H | 2JH6 | 0.72 | |
UBF | 3-({3-[(2S)-2-amino-2-carboxyethyl]- 5-bromo-2,6-dioxo-3,6-dihydropyrimidin- 1(2H)-yl}methyl)thiophene-2-carboxylic acid | A,B | 2QS2 | 0.7 | |
CFX | CEFOXITIN | A,B | 1YMX | 0.72 | |
CFX | CEFOXITIN | A,B | 1I2W | 0.72 | |
SM4 | (1R)-1-(2-THIOPHEN-2-YL-ACETYLAMINO)- 1-(3-(2-CARBOXYVINYL)-PHENYL) METHYLBORONIC ACID | A,B | 2RCX | 0.72 | |
CED | 5-METHYL-2-[2-OXO-1-(2-THIOPHEN- 2-YL-ACETYLAMINO)-ETHYL]-3,6-DIHYDRO- 2H-[1,3]THIAZINE-4-CARBOXYLIC ACID | A | 1GHM | 0.78 | |
701 | (2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}PROPENE-1-SULFONAMIDE | D,H | 2JH0 | 0.72 | |
701 | (2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}PROPENE-1-SULFONAMIDE | A | 2UWO | 0.72 | |
CEO | 5-METHYLENE-2-[2-OXO-1-(2-THIOPHEN- 2-YL-ACETYLAMINO)-ETHYL]-5,6-DIHYDRO- 2H-[1,3]THIAZINE-4-CARBOXYLIC ACID | A,B | 1KVM | 0.72 | |
3SP | N-(CARBOXYMETHYL)-3-CYCLOHEXYL- D-ALANYL-N-({5-[(E)-AMINO(IMINO)METHYL]THIEN- 2-YL}METHYL)-L-PROLINAMIDE | D,H | 2FES | 0.71 |